CLINICAL IMAGING — Clinical MRI

An Attempt to Reconstruct the History of Gradient-System Technology at Siemens

September 1, 2020 by Franz Schmitt

This review discusses first the background in terms of development of these agents and safety discussions therein, proceeds to a discussion of NSF and gadolinium deposition in the brain, and concludes with a discussion of the predictable future – specifically reassessment of the use of the linear GBCAs or a subset thereof. [...]

Filed Under: Clinical Imaging, Software & Hardware Updates
Tagged With: CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES

First Experiences with the World’s First MAGNETOM Vida

June 12, 2017 by Mike Notohamiprodjo MD

This review focuses on 8 critical questions regarding gadolinium deposition in the brain and body, with the answers and discussion therein important for future regulatory decisions and clinical practice. [...]

Filed Under: brain, Clinical Imaging, heart, liver, Software & Hardware Updates, whole body
Tagged With: CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES, CLINICAL UPDATES, NEW TECHNOLOGIES & ADVANCES, SOFTWARE & HARDWARE UPDATES

Reduced Stress and Consistent Contrastenhanced MRI Scans with Precisely Timed, Automated Injection Enabled by MR-Injector Coupling

September 1, 2020 by Gregor Thörmer, Ph.D.

This review discusses first the background in terms of development of these agents and safety discussions therein, proceeds to a discussion of NSF and gadolinium deposition in the brain, and concludes with a discussion of the predictable future – specifically reassessment of the use of the linear GBCAs or a subset thereof. [...]

Filed Under: Clinical Imaging, Contrast Media Updates
Tagged With: CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES, CLINICAL UPDATES, NEW TECHNOLOGIES & ADVANCES, SOFTWARE & HARDWARE UPDATES

Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA’s Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents

May 3, 2017 by Val M. Runge, MD

This review focuses on 8 critical questions regarding gadolinium deposition in the brain and body, with the answers and discussion therein important for future regulatory decisions and clinical practice. [...]

Filed Under: Clinical Imaging, Clinical Methods & Techniques, Clinical Updates, Contrast Media Updates, New Technologies & Advances, Software & Hardware Updates
Tagged With: CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES, CLINICAL UPDATES, NEW TECHNOLOGIES & ADVANCES, SOFTWARE & HARDWARE UPDATES

Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus

June 3, 2016 by Val M. Runge, MD

This review discusses first the background in terms of development of these agents and safety discussions therein, proceeds to a discussion of NSF and gadolinium deposition in the brain, and concludes with a discussion of the predictable future – specifically reassessment of the use of the linear GBCAs or a subset thereof. [...]

Filed Under: Clinical Imaging, Clinical Methods & Techniques, Clinical Updates, Contrast Media Updates, New Technologies & Advances, Software & Hardware Updates
Tagged With: CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES, CLINICAL UPDATES, NEW TECHNOLOGIES & ADVANCES, SOFTWARE & HARDWARE UPDATES

Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis

March 26, 2016 by Val M. Runge, MD

Presented is a review of nephrogenic systemic fibrosis and how this influences daily practice (in contrast enhanced magnetic resonance imaging), with specific clinical recommendations. Download PPTX-zip [...]

Filed Under: Clinical Imaging, Clinical Methods & Techniques, Clinical Updates, Contrast Media Updates, Software & Hardware Updates
Tagged With: CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES, CLINICAL UPDATES, NEW TECHNOLOGIES & ADVANCES, SOFTWARE & HARDWARE UPDATES

Accelerating Clinical MRI in the 21st Century

March 26, 2016 by Val M. Runge, MD

The established class of intravenous contrast media for magnetic resonance imaging is the gadolinium chelates, more generally referred to as the gadolinium-based contrast agents (GBCAs). [...]

Filed Under: Clinical Imaging, Clinical Methods & Techniques, Clinical Updates, Contrast Media Updates, Software & Hardware Updates
Tagged With: CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES, CLINICAL UPDATES, NEW TECHNOLOGIES & ADVANCES, SOFTWARE & HARDWARE UPDATES

Magnetic Resonance Imaging and Computed Tomography of the Brain – 50 Years of Innovation, With a Focus on the Future

March 26, 2016 by Val M. Runge, MD

The established class of intravenous contrast media for magnetic resonance imaging is the gadolinium chelates, more generally referred to as the gadolinium-based contrast agents (GBCAs). [...]

Filed Under: Clinical Imaging, Clinical Methods & Techniques, Clinical Updates, Contrast Media Updates, Software & Hardware Updates
Tagged With: CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES, CLINICAL UPDATES, NEW TECHNOLOGIES & ADVANCES, SOFTWARE & HARDWARE UPDATES

Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus

March 26, 2016 by Val M. Runge, MD

The established class of intravenous contrast media for magnetic resonance imaging is the gadolinium chelates, more generally referred to as the gadolinium-based contrast agents (GBCAs). [...]

Filed Under: brain, Clinical Imaging, Clinical Methods & Techniques, Clinical Updates, Contrast Media Updates
Tagged With: brain, CLINICAL IMAGING, CLINICAL METHODS & TECHNIQUES, CLINICAL UPDATES, NEW TECHNOLOGIES & ADVANCES